SARS-CoV-2 / HBV co-infection: case report

The disease COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has constituted a public health threat worldwide, and it is subsequently declared as a pandemic by WHO. Upper respiratory tract infections are the main manifestations of SARS-CoV-2. However, liver damage has also been reported during the course of the disease in severe cases. In addition to the recently emerged SARS-CoV-2, Hepatitis B Virus (HBV) also occupies a major place in terms of public health. Since both SARS-CoV-2 and HBV can cause hepatitis injury, it is urgent to further investigate SARSCoV-2/HBV co-infection. In this paper, we studied the changes in markers of liver function, inflammation and injury in a patient with inactive HBV. And the possibility of reactivation of the latter after infection with SARS-CoV-2